MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
LENSAR Total Liabilities 2011-2026 | LNSR
Annual Total Liabilities LENSAR
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83.7 M | 47.7 M | 22.4 M | 13.9 M | 11.6 M | 11.9 M | 65.1 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 83.7 M | 11.6 M | 36.6 M |
Quarterly Total Liabilities LENSAR
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.3 M | 79.7 M | 81.3 M | 47.7 M | 25.5 M | 24 M | - | 22.4 M | 20.7 M | 24.8 M | 12.5 M | 13.9 M | 12.2 M | 13.8 M | 10.5 M | 11.6 M | 11.1 M | 10.9 M | 9.21 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 65.1 M | 65.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 82.3 M | 9.21 M | 28.8 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
92.8 M | $ 32.81 | 5.87 % | $ 1.51 B |  USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.36 | 3.48 % | $ 1.67 B | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.39 | 3.53 % | $ 266 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 38.22 | 4.23 % | $ 5.7 K | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 24.45 | 2.8 % | $ 207 M | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.61 | 0.13 % | $ 122 M | USA |
 |
EDAP TMS S.A.
EDAP
|
34.6 M | $ 3.38 | -0.59 % | $ 127 M |  France |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 178.65 | 7.06 % | $ 13.4 B | USA |
 |
Globus Medical
GMED
|
730 M | $ 91.76 | 1.91 % | $ 12.4 B | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.2 | 3.33 % | $ 889 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.91 | 4.37 % | $ 1.16 M | USA |
 |
Nevro Corp.
NVRO
|
323 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.64 | 4.94 % | $ 39.8 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.69 | 3.86 % | $ 746 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 9.87 | 2.02 % | $ 354 M | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 62.67 | 1.33 % | $ 92.8 B | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 11.53 | 4.49 % | $ 1.73 B | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.14 | 10.19 % | $ 19.3 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 36.63 | 5.96 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 87.27 | 2.49 % | $ 3.03 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 16.33 | 3.62 % | $ 383 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 82.18 | 1.68 % | $ 48.1 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 53.86 | -1.01 % | $ 1.58 B | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 64.88 | 2.11 % | $ 3.54 B |  Britain |